Pharma sector braces for tariff risks as US steps up trade actions: Report
India’s pharmaceutical industry may face fresh tariff challenges as the United States intensifies trade actions, according to a recent report. The development has raised concerns among Indian drugmakers, who already account for a significant share of the generic medicines supplied to the US market.
Pharma Sector Braces For Tariff Risks As US Steps | 20/08/2025 | By Darshana | 210
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy